Infectious Diseases News and Research

RSS

Do weather and climate determine where COVID-19 occurs?

A new study provides information on the associations between weather parameters and seasonal coronavirus cases.

1 Nov 2021

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

1 Nov 2021

Can COVID-19 spread through water while swimming?

Scientists explore the evidence on COVID-19 transmission associated with swimming-related activities and the effect of recommended strategies to restrict it.

1 Nov 2021

Prompt procurement and rapid pace of vaccination likely to have a greater impact than vaccine efficacy

For low- and middle-income countries, a COVID-19 vaccination program built on prompt procurement, effective on-the-ground distribution, and a rapid pace of vaccination (the total number of doses given daily) is likely to have a greater public health impact than one focused on relatively small differences in vaccine efficacy, according to a study led by researchers at Massachusetts General Hospital.

30 Oct 2021

Researchers appeal for thoughtful regulation of infectious disease research

COVID-19 has killed close to 5 million people worldwide, and the crisis has given rise to uncertainties about both the origins of the virus and how to respond to future pandemics.

30 Oct 2021

Johns Hopkins Children's Center brings Halloween to pediatric patients

Johns Hopkins Children's Center brought Halloween to pediatric patients today with its annual celebration.

29 Oct 2021

Forgotten antibiotic may be useful in treating severe febrile urinary tract infections

A forgotten antibiotic, temocillin, led to lower selection of resistant bacteria than the standard treatment for febrile urinary tract infection, in a study published in The Lancet Infectious Diseases.

29 Oct 2021

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Research led by scientists at the National Institutes of Health has identified two distinct ways that people with HIV can control the virus for an extended period after stopping antiretroviral therapy (ART) under medical supervision.

29 Oct 2021

Penn's newly created split-engineered base editors show potential for research, therapeutics

Targeted mutations to the genome can now be introduced by splitting specific mutator enzymes and then triggering them to reconstitute, according to research from the Perelman School of Medicine at the University of Pennsylvania.

28 Oct 2021

Study unravels how cells protect against influenza A viruses

Human cells use a protein named TBC1D5 to route influenza A viruses inside host cells for destruction, preventing the virus from spreading replicated copies of itself to other cells, according to a study published in Nature Microbiology.

28 Oct 2021

Malaria: An Interview with the World Health Organization

In this interview, we spoke to Dr. Akpaka Kalu, the World Health Organization's team leader for malaria in Africa, about the groundbreaking malaria vaccine rollout announcement.

28 Oct 2021

People with psychotic disorders at higher risk of hospitalization, death from infectious diseases

People with psychotic or bipolar disorders run a significantly higher risk of hospitalization and death from influenza, pneumonia or sepsis. This is what a new register study at Umeå University, Sweden, is showing.

27 Oct 2021

McMaster-Hamburg collaboration discovers promising new antimalarial compound

A study out of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University has resulted in the discovery of a promising new antimalarial compound.

27 Oct 2021

MU researchers receive $1.9 million grant to assess COVID-19 response in nursing homes

When Lori Popejoy and Amy Vogelsmeier were working as registered nurses early in their careers, they saw firsthand how quickly respiratory infections, such as the common flu, could spread in nursing homes.

27 Oct 2021

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Researchers in the United States have conducted a study showing that Moderna’s coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.

26 Oct 2021

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection.

26 Oct 2021

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Researchers in the United States have developed a cost-effective, high-throughput pipeline for identifying effective nanobodies that target and neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

26 Oct 2021

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers at the Medical University of South Carolina report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after treatment for the hepatitis C virus (HCV), suggesting the possibility of early healing.

26 Oct 2021

DOD funds first human trial of a device to enhance the natural brain cleansing system

The U.S. Department of Defense is funding the first human trial of a device to speed up and enhance the natural system of brain cleansing that occurs when we sleep.

26 Oct 2021

Clinical trial shows no benefit of tamoxifen in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by clinical trial results published in eLife.

26 Oct 2021

Infectious Diseases News and Research

Do weather and climate determine where COVID-19 occurs?

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

Can COVID-19 spread through water while swimming?

Prompt procurement and rapid pace of vaccination likely to have a greater impact than vaccine efficacy

Researchers appeal for thoughtful regulation of infectious disease research

Johns Hopkins Children's Center brings Halloween to pediatric patients

Forgotten antibiotic may be useful in treating severe febrile urinary tract infections

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Penn's newly created split-engineered base editors show potential for research, therapeutics

Study unravels how cells protect against influenza A viruses

Malaria: An Interview with the World Health Organization

People with psychotic disorders at higher risk of hospitalization, death from infectious diseases

McMaster-Hamburg collaboration discovers promising new antimalarial compound

MU researchers receive $1.9 million grant to assess COVID-19 response in nursing homes

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

DOD funds first human trial of a device to enhance the natural brain cleansing system

Clinical trial shows no benefit of tamoxifen in treating deadly fungal meningitis

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News